Retrospective audit of inter-fraction motion for pelvic node radiotherapy in prostate cancer patients

被引:4
作者
Lawes, R. [1 ]
Carter, E. [1 ]
Hussein, M. [1 ]
Murray, J. [1 ,2 ,3 ]
McNair, H. A. [1 ,3 ]
机构
[1] Royal Marsden NHS Fdn Trust, Radiotherapy, Sutton, Surrey, England
[2] Royal Marsden NHS Fdn Trust, Acad Urol Unit, Sutton, Surrey, England
[3] Inst Canc Res, Sutton, Surrey, England
关键词
Prostate cancer; Lymph nodes; Margins; Radiation therapy; RADIATION-THERAPY;
D O I
10.1016/j.radi.2020.08.002
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Introduction: Pelvic lymph nodes move independently to the prostate. When delivering radiotherapy to prostate and pelvic lymph nodes, daily inter- and intra-fraction anatomical changes need to be accounted for. Planning target volume (PTV) margins, grown from the pelvic lymph node clinical target volume need to be determined, to account for this variation in position. Methods: Twenty patients who had daily online image guided radiotherapy to prostate and pelvic lymph nodes between April and December 2018 were selected. Ten pre-treatment verification images using cone beam CT from each patient were registered to pelvic bone anatomy, prostate soft tissue or fiducial markers and pelvic lymph node soft tissue to assess the accuracy of treatment delivery. Population systematic and random errors and PTV margins were calculated. Results: PTV margins of 0.4 cm, 0.4 cm and 0.7 cm lefteright (LR), superioreinferior (SI) and anterior -posterior (AP) respectively were derived for the pelvic lymph nodes when registering to prostate. PTV margins of 0.3 cm, 0.2 cm and 0.4 cm LR, SI and AP respectively were derived for the pelvic lymph nodes when registering to bone. There was a posterior systematic shift of the prostate during the treatment course. Conclusion: There is differential motion of pelvic lymph nodes to prostate and in the era of prostate and pelvic radiotherapy for patients with node positive prostate cancer; there is increasing importance in the accuracy of dose delivery to the involved lymph node. Hence, this group of patients may benefit from personalised radiotherapy PTV margins, especially if the involved pelvic lymph node is within the anterior part of the clinical target volume. Implications for practice: Optimisation of dose delivery to the pelvic lymph nodes when prioritising the prostate in prostate and pelvic lymph node image guided radiotherapy. Crown Copyright (c) 2020 Published by Elsevier Ltd on behalf of The College of Radiographers. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
引用
收藏
页码:266 / 271
页数:6
相关论文
共 17 条
  • [11] Whole-Pelvic Nodal Radiation Therapy in the Context of Hypofractionation for High-Risk Prostate Cancer Patients: A Step Forward
    Kaidar-Person, Orit
    Roach, Mack
    Crehange, Gilles
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013, 86 (04): : 600 - 605
  • [12] Image Guided Radiation Therapy Strategies for Pelvic Lymph Node Irradiation in High-Risk Prostate Cancer: Motion and Margins
    Kershaw, Lucy
    van Zadelhoff, Laila
    Heemsbergen, Wilma
    Pos, Floris
    van Herk, Marcel
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 100 (01): : 68 - 77
  • [13] Progress and Controversies: Radiation Therapy for Prostate Cancer
    Martin, Neil E.
    D'Amico, Anthony V.
    [J]. CA-A CANCER JOURNAL FOR CLINICIANS, 2014, 64 (06) : 389 - 407
  • [14] A comparison of the use of bony anatomy and internal markers for offline verification and an evaluation of the potential benefit of online and offline verification protocols for prostate radiotherapy
    Mcnair, Helen A.
    Hansen, Vibeke N.
    Parker, Christopher C.
    Evans, Phil M.
    Norman, Andrew
    Miles, Elizabeth
    Harris, Emma J.
    Del-Acroix, Louise
    Smith, Elizabeth
    Keane, Richard
    Khoo, Vincent S.
    Thompson, Alan C.
    Dearnaley, David P.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008, 71 (01): : 41 - 50
  • [15] Boost first, eliminate systematic error, and individualize CTV to PTV margin when treating lymph nodes in high-risk prostate cancer
    Rossi, Peter J.
    Schreibmann, Eduard
    Jani, Ashesh B.
    Master, Viraj A.
    Johnstone, Peter A. S.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2009, 90 (03) : 353 - 358
  • [16] The Royal College of Radiologists Society and College of Radiographers Institute of Physical and Engineering in Medicine, 2008, TARG ENS GEOM ACC RA
  • [17] The probability of correct target dosage: Dose-population histograms for deriving treatment margins in radiotherapy
    van Herk, M
    Remeijer, P
    Rasch, C
    Lebesque, JV
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2000, 47 (04): : 1121 - 1135